David P. Schenkein, Director: Denali Therapeutics DNLI Sell · Filed 24/11/13

Trade details

Type: Insider sale
Amount: $870,569.61
Shares · price: 27,129 sh · $32.09 a share
Held after: 41,532 sh
Stock: Denali Therapeutics DNLI
Person: David P. SchenkeinDirector
Trade date: 24/11/11
Filed: 24/11/13
Days to filing: 2 days

Sold 39.5% of holdings

Share of holding sold: 39.5%

Denali Therapeutics trades, last 26 weeks

What else happened in Denali Therapeutics around then

Filed or reported within 30 days of the trade day · 24/10/12~24/12/11

David P. Schenkein's recent trades

David P. SchenkeinDirector
Sell10b5-1 planDenali Therapeutics
Sell10b5-1 plan
Denali Therapeutics
DNLI
$1.1M
32,312 sh
$1.1M
Filed 24/11/13
Traded 24/11/11
David P. SchenkeinDirector
SellAgios Pharmaceuticals
Sell
Agios Pharmaceuticals
AGIO
$2M
57,471 sh
$2M
Filed 24/02/29
Traded 24/02/27
David P. SchenkeinDirector
SellAgios Pharmaceuticals
Sell
Agios Pharmaceuticals
AGIO
$398.4K
11,858 sh
$398.4K
Filed 24/02/29
Traded 24/02/27
David P. SchenkeinDirector
SellAgios Pharmaceuticals
Sell
Agios Pharmaceuticals
AGIO
$1.6M
47,731 sh
$1.6M
Filed 24/02/27
Traded 24/02/23
David P. SchenkeinDirector
SellAgios Pharmaceuticals
Sell
Agios Pharmaceuticals
AGIO
$677.4K
20,411 sh
$677.4K
Filed 24/02/27
Traded 24/02/26